Director, In Silico Discovery – Biologics at Johnson & Johnson

Spring House, Pennsylvania, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Creative and self-motivated leader
Highly collaborative with passion for biologics design and development through computational techniques
Expertise in computational antibody design
Ability to manage interactions with portfolio project teams and ensure optimal computational techniques
Experience working closely with In Silico Discovery and Biologics Discovery teams
Skills in significant collaboration, change management, and external outreach
Knowledge to stay at the forefront of computational design and AI/ML for biologics

Responsibilities

Lead a core group of computational antibody design scientists
Key contributor in developing a comprehensive strategy to stay at the forefront of innovation in computational design and AI/ML for Biologics Therapeutics
Implement and apply the computational biologics design and optimization strategy
Partner closely with Biologics Discovery teams to apply custom predictive and AI/ML tools for biologics design and optimization across portfolio projects
Mentor junior scientists, fostering their development as expert informatics scientists
Engage in industry consortia and represent Janssen and In Silico Discovery in key initiatives
Periodically evaluate and make recommendations for the acquisition or building of new technologies, including performing Due Diligence on potential partnering/M&A opportunities
Report directly to the Senior Director of In Silico Biologics and play a pivotal role in shaping strategies and initiatives to advance biologics discovery

Skills

Machine Learning

In Silico Discovery

Biologics Design

Computational Biology

Data Science

Leadership

Johnson & Johnson

Healthcare products in pharmaceuticals and devices.

About Johnson & Johnson

Johnson & Johnson operates in the healthcare sector with three main areas: pharmaceuticals, medical devices, and consumer health products. In the pharmaceuticals segment, the company develops prescription drugs for various medical conditions such as cancer and infectious diseases. The medical devices segment provides products used in surgeries and other medical procedures, while the consumer health segment offers over-the-counter products, including baby care and personal health items. Johnson & Johnson generates revenue through direct sales and partnerships, and it invests significantly in research and development to create new products that meet the needs of consumers and healthcare providers. The company stands out from competitors by emphasizing diversity, equity, and inclusion in its workplace, fostering an environment where employees can share their perspectives. Its goal is to improve patient outcomes and enhance the overall health and well-being of individuals globally.

New Brunswick, New JerseyHeadquarters

1886Year Founded

IPOCompany Stage

HealthcareIndustries

10,001+Employees

Risks

J&J faces a class action lawsuit in Australia over ineffective cold and flu medications.

Former J&J executives joining other firms could lead to increased competition.

Ongoing legal battles, like the lawsuit against Cigna, pose financial liabilities for J&J.

Differentiation

J&J operates in three segments: pharmaceuticals, medical devices, and consumer health.

The company invests heavily in R&D for innovative medical solutions and products.

J&J is committed to diversity, equity, and inclusion in its workplace culture.

Upsides

J&J's collaboration with Helsinki University Hospital focuses on value-based healthcare models.

The rise of personalized medicine offers J&J opportunities in targeted therapies.

Increased focus on digital health solutions presents expansion opportunities for J&J.

Land your dream remote job 3x faster with AI

Try Jobo Free